Interview Paul Chilo Director of Governance, Risk & Compliance at SOPHiA GENETICS - SOPHiA UNITY

Here is the latest interview with one of our clients - SOPHiA GENETICS,. SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA.

They believed technology could make a positive and lasting impact on the world, using data for good.Their vision was to build a future in which each patient has equal access to world-class care, and today, they are well underway to realizing that impact. SOPHia has built a  technology platform that distills complex data into actionable insights to reshape the way that cancer and rare inherited disorders are diagnosed and treated.

In this interview with Paul Chilo, Director of Governance, Risk & Compliance at SOPHiA GENETICS, we explore the latest initiative, UNITY, a global oncology platform. We discuss SOPHiA GENETICS’ compliance strategy for this international project, as well as our collaboration and partnership in bringing it to life.

‍